215 related articles for article (PubMed ID: 16195134)
1. Orthostatic side effects of clomipramine and moclobemide during treatment for depression.
Stage KB;
Nord J Psychiatry; 2005; 59(4):298-301. PubMed ID: 16195134
[TBL] [Abstract][Full Text] [Related]
2. Use of bupropion in patients who exhibit orthostatic hypotension on tricyclic antidepressants.
Farid FF; Wenger TL; Tsai SY; Singh BN; Stern WC
J Clin Psychiatry; 1983 May; 44(5 Pt 2):170-3. PubMed ID: 6406451
[TBL] [Abstract][Full Text] [Related]
3. Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
Guelfi JD; Payan C; Fermanian J; Pedarriosse AM; Manfredi R
Br J Psychiatry; 1992 Apr; 160():519-24. PubMed ID: 1571752
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
Becker T; Struck M; Laux G
Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
[TBL] [Abstract][Full Text] [Related]
5. Orthostatic side effects of clomipramine and citalopram during treatment for depression.
Christensen P; Thomsen HY; Pedersen OL; Gram LF; Kragh-Sørensen P
Psychopharmacology (Berl); 1985; 86(4):383-5. PubMed ID: 3929308
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of orthostatic hypotension induced by tricyclic antidepressants with yohimbine (author's transl)].
des Lauriers A; Widlocher D; Allilaire JF; Lecrubier Y; Simon P
Ann Med Interne (Paris); 1980; 131(8):508-9. PubMed ID: 7224460
[TBL] [Abstract][Full Text] [Related]
7. The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine.
Bech P; Stage KB; Larsen JK; Vestergaard P; Gram LF;
J Affect Disord; 2012 Nov; 140(3):253-9. PubMed ID: 22381949
[TBL] [Abstract][Full Text] [Related]
8. Moclobemide: therapeutic use and clinical studies.
Bonnet U
CNS Drug Rev; 2003; 9(1):97-140. PubMed ID: 12595913
[TBL] [Abstract][Full Text] [Related]
9. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
[No Abstract] [Full Text] [Related]
10. Intravenous chlorimipramine and depressive subtypes.
Escobar JI; Teeter RR; Tuason VB; Schiele BC
Dis Nerv Syst; 1976 Jun; 37(6):325-8. PubMed ID: 1277983
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
12. Moclobemide and clomipramine in reactive depression. A placebo-controlled randomized clinical trial.
Larsen JK; Holm P; Høyer E; Mejlhede A; Mikkelsen PL; Olesen A; Schaumburg E
Acta Psychiatr Scand; 1989 Jun; 79(6):530-6. PubMed ID: 2669441
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
14. Moclobemide and clomipramine in endogenous depression. A randomized clinical trial.
Koczkas C; Holm P; Karlsson A; Nagy A; Ose E; Pétursson H; Ulverås L; Wenedikter O
Acta Psychiatr Scand; 1989 Jun; 79(6):523-9. PubMed ID: 2669440
[TBL] [Abstract][Full Text] [Related]
15. Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression.
Larsen JK; Gjerris A; Holm P; Anderson J; Bille A; Christensen EM; Høyer E; Jensen H; Mejlhede A; Langagergaard A
Acta Psychiatr Scand; 1991 Dec; 84(6):564-70. PubMed ID: 1792931
[TBL] [Abstract][Full Text] [Related]
16. Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor--results of the drug utilization observation studies.
Delini-Stula A; Baier D; Kohnen R; Laux G; Philipp M; Scholz HJ
Pharmacopsychiatry; 1999 Mar; 32(2):61-7. PubMed ID: 10333164
[TBL] [Abstract][Full Text] [Related]
17. Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study.
Kragh-Sørensen P; Müller B; Andersen JV; Buch D; Stage KB
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):24S-30S. PubMed ID: 7593726
[TBL] [Abstract][Full Text] [Related]
18. Age-related adverse drug reactions to clomipramine.
Stage KB; Kragh-Sørensen PB;
Acta Psychiatr Scand; 2002 Jan; 105(1):55-9. PubMed ID: 12086226
[TBL] [Abstract][Full Text] [Related]
19. Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine.
Lacomblez L; Bensimon G; Isnard F; Diquet B; Lecrubier Y; Puech AJ
Clin Pharmacol Ther; 1989 Mar; 45(3):241-51. PubMed ID: 2920499
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of therapeutic doses of tricyclic antidepressants: importance of blood level monitoring.
Smith RC; Chojnacki M; Hu R; Mann E
J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):57-63. PubMed ID: 7440526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
